Do analysts rate CYAB or HOLO?

Cyabra currently has a consensus target price of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cyabra is more favorable than MicroCloud Hologram. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cyabra 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 MicroCloud Hologram 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is CYAB or HOLO more profitable?

Company Net Margins Return on Equity Return on Assets Cyabra N/A N/A -169.20% MicroCloud Hologram N/A N/A N/A

Do analysts recommend STIX or CYAB?

Cyabra has a consensus price target of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, analysts clearly believe Cyabra is more favorable than Semantix. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semantix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cyabra 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is STIX or CYAB more profitable?

Cyabra has a net margin of 0.00% compared to Semantix's net margin of -69.49%. Cyabra's return on equity of 0.00% beat Semantix's return on equity. Company Net Margins Return on Equity Return on Assets Semantix -69.49% -45.45% -26.98% Cyabra N/A N/A -169.20%

Do analysts recommend CYAB or GRDX?

Cyabra currently has a consensus price target of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, equities research analysts plainly believe Cyabra is more favorable than Entero Therapeutics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cyabra 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Entero Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is CYAB or GRDX more profitable?

Cyabra's return on equity of 0.00% beat Entero Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Cyabra N/A N/A -169.20% Entero Therapeutics N/A -47.34% -16.07%

Do analysts prefer CYAB or RPGL?

Cyabra currently has a consensus price target of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, analysts plainly believe Cyabra is more favorable than Republic Power Group Limited Class A Ordinary Shares. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cyabra 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Republic Power Group Limited Class A Ordinary Shares 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, CYAB or RPGL?

Republic Power Group Limited Class A Ordinary Shares has higher revenue and earnings than Cyabra. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cyabra N/A N/A -$8.29M -$3.36 N/A Republic Power Group Limited Class A Ordinary Shares $2.37M 10.12 $280K N/A N/A

Is CYAB or RPGL more profitable?

Company Net Margins Return on Equity Return on Assets Cyabra N/A N/A -169.20% Republic Power Group Limited Class A Ordinary Shares N/A N/A N/A

Do analysts prefer TGHL or CYAB?

Cyabra has a consensus target price of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, analysts clearly believe Cyabra is more favorable than GrowHub. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GrowHub 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cyabra 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, TGHL or CYAB?

Cyabra has lower revenue, but higher earnings than GrowHub. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GrowHub $83.03K 288.61 -$13.38M N/A N/A Cyabra N/A N/A -$8.29M -$3.36 N/A

Is TGHL or CYAB more profitable?

Company Net Margins Return on Equity Return on Assets GrowHub N/A N/A N/A Cyabra N/A N/A -169.20%

Cyabra (CYAB) Competitors

$0.33 +0.01 (+1.96%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$0.32 -0.01 (-3.93%)

As of 09/11/2026 07:56 PM Eastern

Compare

CYAB vs. HOLO, STIX, GRDX, RPGL, and TGHL

Should you buy Cyabra stock or one of its competitors? Cyabra's main competitors and comparable companies include MicroCloud Hologram (HOLO), Semantix (STIX), Entero Therapeutics (GRDX), Republic Power Group Limited Class A Ordinary Shares (RPGL), and GrowHub (TGHL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "software" industry.

How does Cyabra compare to MicroCloud Hologram?

Cyabra (NASDAQ:CYAB) and MicroCloud Hologram (NASDAQ:HOLO) are both small-cap technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

MicroCloud Hologram has higher revenue and earnings than Cyabra. Cyabra is trading at a lower price-to-earnings ratio than MicroCloud Hologram, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cyabra	N/A	N/A	-$8.29M	-$3.36	N/A
MicroCloud Hologram	$457.86M	0.05	-$7.38M	-$320.00	N/A

In the previous week, Cyabra had 3 more articles in the media than MicroCloud Hologram. MarketBeat recorded 4 mentions for Cyabra and 1 mentions for MicroCloud Hologram. MicroCloud Hologram's average media sentiment score of 0.94 beat Cyabra's score of 0.17 indicating that MicroCloud Hologram is being referred to more favorably in the news media.

Company	Overall Sentiment
Cyabra	Neutral
MicroCloud Hologram	Positive

77.1% of Cyabra shares are held by institutional investors. Comparatively, 2.1% of MicroCloud Hologram shares are held by institutional investors. 17.5% of Cyabra shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cyabra currently has a consensus target price of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cyabra is more favorable than MicroCloud Hologram.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cyabra	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MicroCloud Hologram	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cyabra has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, MicroCloud Hologram has a beta of 2.92, indicating that its share price is 192% more volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Cyabra	N/A	N/A	-169.20%
MicroCloud Hologram	N/A	N/A	N/A

Summary

Cyabra beats MicroCloud Hologram on 7 of the 13 factors compared between the two stocks.

How does Cyabra compare to Semantix?

Semantix (NASDAQ:STIX) and Cyabra (NASDAQ:CYAB) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Cyabra has a consensus price target of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, analysts clearly believe Cyabra is more favorable than Semantix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semantix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cyabra	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Cyabra had 4 more articles in the media than Semantix. MarketBeat recorded 4 mentions for Cyabra and 0 mentions for Semantix. Cyabra's average media sentiment score of 0.17 beat Semantix's score of 0.00 indicating that Cyabra is being referred to more favorably in the news media.

Company	Overall Sentiment
Semantix	Neutral
Cyabra	Neutral

40.1% of Semantix shares are owned by institutional investors. Comparatively, 77.1% of Cyabra shares are owned by institutional investors. 35.5% of Semantix shares are owned by insiders. Comparatively, 17.5% of Cyabra shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Cyabra has lower revenue, but higher earnings than Semantix. Cyabra is trading at a lower price-to-earnings ratio than Semantix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Semantix	$264.23M	0.00	-$63.61M	-$0.81	N/A
Cyabra	N/A	N/A	-$8.29M	-$3.36	N/A

Semantix has a beta of -0.37, meaning that its share price is 137% less volatile than the broader market. Comparatively, Cyabra has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market.

Cyabra has a net margin of 0.00% compared to Semantix's net margin of -69.49%. Cyabra's return on equity of 0.00% beat Semantix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Semantix	-69.49%	-45.45%	-26.98%
Cyabra	N/A	N/A	-169.20%

Summary

Cyabra beats Semantix on 10 of the 15 factors compared between the two stocks.

How does Cyabra compare to Entero Therapeutics?

Cyabra (NASDAQ:CYAB) and Entero Therapeutics (NASDAQ:GRDX) are both small-cap technology companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

77.1% of Cyabra shares are held by institutional investors. Comparatively, 12.3% of Entero Therapeutics shares are held by institutional investors. 17.5% of Cyabra shares are held by company insiders. Comparatively, 0.8% of Entero Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cyabra's return on equity of 0.00% beat Entero Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cyabra	N/A	N/A	-169.20%
Entero Therapeutics	N/A	-47.34%	-16.07%

Cyabra has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, Entero Therapeutics has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market.

Cyabra currently has a consensus price target of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, equities research analysts plainly believe Cyabra is more favorable than Entero Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cyabra	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Entero Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Entero Therapeutics has higher revenue and earnings than Cyabra. Entero Therapeutics is trading at a lower price-to-earnings ratio than Cyabra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cyabra	N/A	N/A	-$8.29M	-$3.36	N/A
Entero Therapeutics	$160.34K	127.20	-$6.39M	-$1.90	N/A

In the previous week, Cyabra had 2 more articles in the media than Entero Therapeutics. MarketBeat recorded 4 mentions for Cyabra and 2 mentions for Entero Therapeutics. Entero Therapeutics' average media sentiment score of 1.43 beat Cyabra's score of 0.17 indicating that Entero Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Cyabra	Neutral
Entero Therapeutics	Positive

Summary

Cyabra beats Entero Therapeutics on 8 of the 14 factors compared between the two stocks.

How does Cyabra compare to Republic Power Group Limited Class A Ordinary Shares?

Cyabra (NASDAQ:CYAB) and Republic Power Group Limited Class A Ordinary Shares (NASDAQ:RPGL) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
Cyabra	N/A	N/A	-169.20%
Republic Power Group Limited Class A Ordinary Shares	N/A	N/A	N/A

Cyabra currently has a consensus price target of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, analysts plainly believe Cyabra is more favorable than Republic Power Group Limited Class A Ordinary Shares.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cyabra	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Republic Power Group Limited Class A Ordinary Shares	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Cyabra had 3 more articles in the media than Republic Power Group Limited Class A Ordinary Shares. MarketBeat recorded 4 mentions for Cyabra and 1 mentions for Republic Power Group Limited Class A Ordinary Shares. Republic Power Group Limited Class A Ordinary Shares' average media sentiment score of 1.88 beat Cyabra's score of 0.17 indicating that Republic Power Group Limited Class A Ordinary Shares is being referred to more favorably in the news media.

Company	Overall Sentiment
Cyabra	Neutral
Republic Power Group Limited Class A Ordinary Shares	Very Positive

77.1% of Cyabra shares are held by institutional investors. 17.5% of Cyabra shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Republic Power Group Limited Class A Ordinary Shares has higher revenue and earnings than Cyabra.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cyabra	N/A	N/A	-$8.29M	-$3.36	N/A
Republic Power Group Limited Class A Ordinary Shares	$2.37M	10.12	$280K	N/A	N/A

Summary

Cyabra beats Republic Power Group Limited Class A Ordinary Shares on 6 of the 10 factors compared between the two stocks.

How does Cyabra compare to GrowHub?

GrowHub (NASDAQ:TGHL) and Cyabra (NASDAQ:CYAB) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Cyabra has a consensus target price of $1.00, suggesting a potential upside of 200.21%. Given Cyabra's stronger consensus rating and higher possible upside, analysts clearly believe Cyabra is more favorable than GrowHub.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GrowHub	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cyabra	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
GrowHub	N/A	N/A	N/A
Cyabra	N/A	N/A	-169.20%

77.1% of Cyabra shares are held by institutional investors. 17.5% of Cyabra shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Cyabra had 2 more articles in the media than GrowHub. MarketBeat recorded 4 mentions for Cyabra and 2 mentions for GrowHub. GrowHub's average media sentiment score of 1.43 beat Cyabra's score of 0.17 indicating that GrowHub is being referred to more favorably in the media.

Company	Overall Sentiment
GrowHub	Positive
Cyabra	Neutral

Cyabra has lower revenue, but higher earnings than GrowHub.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GrowHub	$83.03K	288.61	-$13.38M	N/A	N/A
Cyabra	N/A	N/A	-$8.29M	-$3.36	N/A

Summary

Cyabra beats GrowHub on 7 of the 10 factors compared between the two stocks.

Get Cyabra News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CYAB vs. The Competition

Export

Metric	Cyabra	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$5.75M	$15.42B	$29.64B	$12.72B
Dividend Yield	N/A	3.43%	2.74%	11.15%
P/E Ratio	-0.10	138.41	76.55	25.29
Price / Sales	N/A	1,286.68	588.63	98.94
Price / Cash	N/A	45.12	47.50	51.44
Price / Book	-0.05	8.34	7.70	6.20
Net Income	-$8.29M	$434.47M	$704.99M	$358.50M
7 Day Performance	-10.26%	-2.04%	-1.08%	-2.35%
1 Month Performance	-0.83%	-1.09%	-3.65%	-2.77%
1 Year Performance	N/A	-0.19%	180.35%	7.63%

Cyabra Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CYAB Cyabra	3.1887 of 5 stars	$0.33 +2.0%	$1.00 +200.2%	N/A	$5.75M	N/A	N/A	53	Short Interest Increase Gap Up
HOLO MicroCloud Hologram	0.5957 of 5 stars	$1.72 flat	N/A	-69.4%	$25.06M	$56.52M	N/A	2	Gap Up
STIX Semantix	N/A	N/A	N/A	N/A	$23.73M	$264.23M	N/A	4
GRDX Entero Therapeutics	1.5404 of 5 stars	$3.25 flat	N/A	N/A	$23.18M	$40K	N/A	9	Short Interest Decrease Gap Down
RPGL Republic Power Group Limited Class A Ordinary Shares	N/A	$1.33 flat	N/A	N/A	$21.41M	$2.37M	N/A	N/A	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CYAB) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cyabra (CYAB) Competitors

CYAB vs. HOLO, STIX, GRDX, RPGL, and TGHL

How does Cyabra compare to MicroCloud Hologram?

Summary

How does Cyabra compare to Semantix?

Summary

How does Cyabra compare to Entero Therapeutics?

Summary

How does Cyabra compare to Republic Power Group Limited Class A Ordinary Shares?

Summary

How does Cyabra compare to GrowHub?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CYAB vs. The Competition

Cyabra Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cyabra (CYAB) Competitors

CYAB vs. HOLO, STIX, GRDX, RPGL, and TGHL

How does Cyabra compare to MicroCloud Hologram?

Which has better valuation and earnings, CYAB or HOLO?

Does the media prefer CYAB or HOLO?

Do institutionals and insiders have more ownership in CYAB or HOLO?

Do analysts rate CYAB or HOLO?

Which has more volatility and risk, CYAB or HOLO?

Is CYAB or HOLO more profitable?

Summary

How does Cyabra compare to Semantix?

Do analysts recommend STIX or CYAB?

Does the media favor STIX or CYAB?

Do institutionals & insiders hold more shares of STIX or CYAB?

Which has preferable valuation and earnings, STIX or CYAB?

Which has more risk and volatility, STIX or CYAB?

Is STIX or CYAB more profitable?

Summary

How does Cyabra compare to Entero Therapeutics?

Do institutionals and insiders have more ownership in CYAB or GRDX?

Is CYAB or GRDX more profitable?

Which has more risk & volatility, CYAB or GRDX?

Do analysts recommend CYAB or GRDX?

Which has preferable valuation and earnings, CYAB or GRDX?

Does the media prefer CYAB or GRDX?

Summary

How does Cyabra compare to Republic Power Group Limited Class A Ordinary Shares?

Is CYAB or RPGL more profitable?

Do analysts prefer CYAB or RPGL?

Does the media refer more to CYAB or RPGL?

Do insiders & institutionals have more ownership in CYAB or RPGL?

Which has better valuation & earnings, CYAB or RPGL?

Summary

How does Cyabra compare to GrowHub?

Do analysts prefer TGHL or CYAB?

Is TGHL or CYAB more profitable?

Do institutionals and insiders have more ownership in TGHL or CYAB?

Does the media favor TGHL or CYAB?

Which has higher valuation and earnings, TGHL or CYAB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CYAB vs. The Competition

Cyabra Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools